{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:18:38Z","timestamp":1770340718822,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was financially supported by the National Program on Key Research Project of China.","award":["(2023YFD1802501)"],"award-info":[{"award-number":["(2023YFD1802501)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"DOI":"10.1007\/s00253-025-13561-8","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:54:27Z","timestamp":1757577267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Foot-and-mouth disease virus vaccine with VP1 G-H loop substitution of the Cathay strain broadens antigen spectrum"],"prefix":"10.1007","volume":"109","author":[{"given":"Jingjing","family":"Zha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingwen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanfang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"OuYang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"issue":"2","key":"13561_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1128\/jvi.74.2.987-991.2000","volume":"74","author":"CW Beard","year":"2000","unstructured":"Beard CW, Mason PW (2000) Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol 74(2):987\u2013991. https:\/\/doi.org\/10.1128\/jvi.74.2.987-991.2000","journal-title":"J Virol"},{"issue":"9","key":"13561_CR3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s10529-016-2121-4","volume":"38","author":"JK Biswal","year":"2016","unstructured":"Biswal JK, Ranjan R, Pattnaik B (2016) Chimeric foot-and-mouth disease virus serotype O displaying a serotype Asia1 antigenic epitope at the surface. Biotechnol Lett 38(9):1509\u20131517. https:\/\/doi.org\/10.1007\/s10529-016-2121-4","journal-title":"Biotechnol Lett"},{"issue":"1","key":"13561_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/vim.1995.8.11","volume":"8","author":"B Borrego","year":"1995","unstructured":"Borrego B, Camarero JA, Mateu MG, Domingo E (1995) A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance. Viral Immunol 8(1):11\u201318. https:\/\/doi.org\/10.1089\/vim.1995.8.11","journal-title":"Viral Immunol"},{"issue":"1","key":"13561_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1128\/jvi.73.1.251-259.1999","volume":"73","author":"UJ Buchholz","year":"1999","unstructured":"Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73(1):251\u2013259. https:\/\/doi.org\/10.1128\/jvi.73.1.251-259.1999","journal-title":"J Virol"},{"issue":"19","key":"13561_CR6","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.1128\/jvi.00577-06","volume":"80","author":"A Burman","year":"2006","unstructured":"Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T (2006) Specificity of the VP1 GH loop of foot-and-mouth disease virus for \u03b1v integrins. J Virol 80(19):9798\u20139810. https:\/\/doi.org\/10.1128\/jvi.00577-06","journal-title":"J Virol"},{"issue":"4","key":"13561_CR7","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/tbed.13497","volume":"67","author":"R Ca\u00f1as-Arranz","year":"2020","unstructured":"Ca\u00f1as-Arranz R, Forner M, Defaus S, Rodr\u00edguez-Pulido M, de Le\u00f3n P, Torres E, Bustos MJ, Borrego B, S\u00e1iz M, Blanco E, Andreu D, Sobrino F (2020) A bivalent B-cell epitope dendrimer peptide can confer long-lasting immunity in swine against foot-and-mouth disease. Transbound Emerg Dis 67(4):1614\u20131622. https:\/\/doi.org\/10.1111\/tbed.13497","journal-title":"Transbound Emerg Dis"},{"issue":"4","key":"13561_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/vaccines9040387","volume":"9","author":"Y Cao","year":"2021","unstructured":"Cao Y, Li K, Xing X, Bao H, Huang N, Zhu G, Bai X, Sun P, Fu Y, Li P, Zhang J, Ma X, Li D, Liu Z, Lu Z (2021) Selection of vaccine candidate for foot-and-mouth disease virus serotype O using a blocking enzyme-linked immunosorbent assay. Vaccines (Basel) 9(4):387. https:\/\/doi.org\/10.3390\/vaccines9040387","journal-title":"Vaccines (Basel)"},{"issue":"20","key":"13561_CR9","doi-asserted-by":"publisher","first-page":"11341","DOI":"10.1128\/jvi.00930-07","volume":"81","author":"C Carrillo","year":"2007","unstructured":"Carrillo C, Lu Z, Borca MV, Vagnozzi A, Kutish GF, Rock DL (2007) Genetic and phenotypic variation of foot-and-mouth disease virus during serial passages in a natural host. J Virol 81(20):11341\u201311351. https:\/\/doi.org\/10.1128\/jvi.00930-07","journal-title":"J Virol"},{"issue":"Pt 8","key":"13561_CR10","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1099\/0022-1317-74-8-1547","volume":"74","author":"JR Crowther","year":"1993","unstructured":"Crowther JR, Farias S, Carpenter WC, Samuel AR (1993) Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 74(Pt 8):1547\u20131553. https:\/\/doi.org\/10.1099\/0022-1317-74-8-1547","journal-title":"J Gen Virol"},{"issue":"5\u20136","key":"13561_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0147-9571(02)00030-9","volume":"25","author":"G Davies","year":"2002","unstructured":"Davies G (2002) The foot and mouth disease (FMD) epidemic in the United Kingdom 2001. Comp Immunol Microbiol Infect Dis 25(5\u20136):331\u2013343. https:\/\/doi.org\/10.1016\/s0147-9571(02)00030-9","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"7","key":"13561_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/vr.141.7.174","volume":"141","author":"CS Dunn","year":"1997","unstructured":"Dunn CS, Donaldson AI (1997) Natural adaption to pigs of a Taiwanese isolate of foot-and-mouth disease virus. Vet Rec 141(7):174\u2013175. https:\/\/doi.org\/10.1136\/vr.141.7.174","journal-title":"Vet Rec"},{"issue":"1","key":"13561_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13567-025-01485-0","volume":"56","author":"A Elrashedy","year":"2025","unstructured":"Elrashedy A, Nayel M, Salama A, Zaghawa A, El-Shabasy RM, Hasan ME (2025) Foot-and-mouth disease: genomic and proteomic structure, antigenic sites, serotype relationships, immune evasion, recent vaccine development strategies, and future perspectives. Vet Res 56(1):78. https:\/\/doi.org\/10.1186\/s13567-025-01485-0","journal-title":"Vet Res"},{"key":"13561_CR14","doi-asserted-by":"publisher","first-page":"105311","DOI":"10.1016\/j.prevetmed.2021.105311","volume":"189","author":"H Gao","year":"2021","unstructured":"Gao H, Ma J (2021) Spatial distribution and risk areas of foot and mouth disease in mainland China. Prev Vet Med 189:105311. https:\/\/doi.org\/10.1016\/j.prevetmed.2021.105311","journal-title":"Prev Vet Med"},{"issue":"2","key":"13561_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/cmr.17.2.465-493.2004","volume":"17","author":"MJ Grubman","year":"2004","unstructured":"Grubman MJ, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17(2):465\u2013493. https:\/\/doi.org\/10.1128\/cmr.17.2.465-493.2004","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"13561_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/vaccines11091487","volume":"11","author":"SY Hwang","year":"2023","unstructured":"Hwang SY, Shin SH, Park SH, Lee MJ, Kim SM, Lee JS, Park JH (2023) Serological conversion through a second exposure to inactivated foot-and-mouth disease virus expressing the JC epitope on the viral surface. Vaccines (Basel) 11(9):1487. https:\/\/doi.org\/10.3390\/vaccines11091487","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"13561_CR17","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1128\/jvi.78.9.4533-4540.2004","volume":"78","author":"T Jackson","year":"2004","unstructured":"Jackson T, Clark S, Berryman S, Burman A, Cambier S, Mu D, Nishimura S, King AM (2004) Integrin \u03b1V\u03b28 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol 78(9):4533\u20134540. https:\/\/doi.org\/10.1128\/jvi.78.9.4533-4540.2004","journal-title":"J Virol"},{"issue":"6","key":"13561_CR18","doi-asserted-by":"publisher","first-page":"e01693","DOI":"10.1128\/jvi.01693-16","volume":"91","author":"SM Kim","year":"2017","unstructured":"Kim SM, Kim YI, Park SJ, Kim EH, Kwon HI, Si YJ, Lee IW, Song MS, Choi YK (2017) Vaccine efficacy of inactivated, chimeric hemagglutinin H9\/H5N2 avian influenza virus and its suitability for the marker vaccine strategy. J Virol 91(6):e01693-e1716. https:\/\/doi.org\/10.1128\/jvi.01693-16","journal-title":"J Virol"},{"issue":"3\u20134","key":"13561_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.prevetmed.2013.07.013","volume":"112","author":"TJ Knight-Jones","year":"2013","unstructured":"Knight-Jones TJ, Rushton J (2013) The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur? Prev Vet Med 112(3\u20134):161\u2013173. https:\/\/doi.org\/10.1016\/j.prevetmed.2013.07.013","journal-title":"Prev Vet Med"},{"issue":"1","key":"13561_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0168-1702(02)00260-5","volume":"91","author":"NJ Knowles","year":"2003","unstructured":"Knowles NJ, Samuel AR (2003) Molecular epidemiology of foot-and-mouth disease virus. Virus Res 91(1):65\u201380. https:\/\/doi.org\/10.1016\/s0168-1702(02)00260-5","journal-title":"Virus Res"},{"issue":"16","key":"13561_CR21","doi-asserted-by":"publisher","first-page":"e00155","DOI":"10.1128\/jvi.00155-17","volume":"91","author":"SY Lee","year":"2017","unstructured":"Lee SY, Lee YJ, Kim RH, Park JN, Park ME, Ko MK, Choi JH, Chu JQ, Lee KN, Kim SM, Tark D, Lee HS, Ko YJ, Seo MG, Park JW, Kim B, Lee MH, Lee JS, Park JH (2017) Rapid engineering of foot-and-mouth disease vaccine and challenge viruses. J Virol 91(16):e00155-e217. https:\/\/doi.org\/10.1128\/jvi.00155-17","journal-title":"J Virol"},{"key":"13561_CR22","doi-asserted-by":"publisher","first-page":"104920","DOI":"10.1016\/j.antiviral.2020.104920","volume":"182","author":"G Lee","year":"2020","unstructured":"Lee G, Hwang JH, Park JH, Lee MJ, Kim B, Kim SM (2020) Vaccine strain of O\/ME-SA\/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage. Antiviral Res 182:104920. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104920","journal-title":"Antiviral Res"},{"key":"13561_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1746-6148-8-57","volume":"8","author":"P Li","year":"2012","unstructured":"Li P, Bai X, Sun P, Li D, Lu Z, Cao Y, Fu Y, Bao H, Chen Y, Xie B, Liu Z (2012) Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics. BMC Vet Res 8:57. https:\/\/doi.org\/10.1186\/1746-6148-8-57","journal-title":"BMC Vet Res"},{"issue":"1","key":"13561_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13567-022-01072-7","volume":"53","author":"P Li","year":"2022","unstructured":"Li P, Huang S, Zha J, Sun P, Li D, Bao H, Cao Y, Bai X, Fu Y, Ma X, Li K, Yuan H, Zhang J, Zhao Z, Wang J, Zhang K, Chen Y, Zhang Q, Qi S, Liu Z, Lu Z (2022) Evaluation of immunogenicity and cross-reactive responses of vaccines prepared from two chimeric serotype O foot-and-mouth disease viruses in pigs and cattle. Vet Res 53(1):56. https:\/\/doi.org\/10.1186\/s13567-022-01072-7","journal-title":"Vet Res"},{"key":"13561_CR25","doi-asserted-by":"publisher","first-page":"1147652","DOI":"10.3389\/fmicb.2023.1147652","volume":"14","author":"F Li","year":"2023","unstructured":"Li F, Li Y, Ma J, Wu R, Zou X, Liu Y, Zhao Q, Zhu Y (2023) Molecular evolution, diversity, and adaptation of foot-and-mouth disease virus serotype O in Asia. Front Microbiol 14:1147652. https:\/\/doi.org\/10.3389\/fmicb.2023.1147652","journal-title":"Front Microbiol"},{"issue":"10","key":"13561_CR26","doi-asserted-by":"publisher","first-page":"e1012623","DOI":"10.1371\/journal.ppat.1012623","volume":"20","author":"F Li","year":"2024","unstructured":"Li F, Wu S, Lv L, Huang S, Zhang Z, Zerang Z, Li P, Cao Y, Bao H, Sun P, Bai X, He Y, Fu Y, Yuan H, Ma X, Zhao Z, Zhang J, Wang J, Wang T, Li D, Zhang Q, He J, Liu Z, Lu Z, Lei D, Li K (2024) Discovery, recognized antigenic structures, and evolution of cross-serotype broadly neutralizing antibodies from porcine B-cell repertoires against foot-and-mouth disease virus. PLoS Pathog 20(10):e1012623. https:\/\/doi.org\/10.1371\/journal.ppat.1012623","journal-title":"PLoS Pathog"},{"key":"13561_CR27","doi-asserted-by":"publisher","unstructured":"Li J, Hou G, Wang Y, Wang S, Cheng S, Peng C, Jiang W (2018) Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades 2.3.4.4 and 2.3.2.1. J Gen Virol 99(12):1600\u20131607. https:\/\/doi.org\/10.1099\/jgv.0.001140","DOI":"10.1099\/jgv.0.001140"},{"key":"13561_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.meegid.2016.01.009","volume":"39","author":"K Lian","year":"2016","unstructured":"Lian K, Yang F, Zhu Z, Cao W, Jin Y, Liu H, Li D, Zhang K, Guo J, Liu X, Zheng H (2016) The VP1 S154D mutation of type Asia1 foot-and-mouth disease virus enhances viral replication and pathogenicity. Infect Genet Evol 39:113\u2013119. https:\/\/doi.org\/10.1016\/j.meegid.2016.01.009","journal-title":"Infect Genet Evol"},{"issue":"33","key":"13561_CR29","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1016\/j.vaccine.2016.06.007","volume":"34","author":"X Liao","year":"2016","unstructured":"Liao X, Wang Z, Cao T, Tong C, Geng S, Gu Y, Zhou Y, Li X, Fang W (2016) Hypervariable antigenic region 1 of classical swine fever virus E2 protein impacts antibody neutralization. Vaccine 34(33):3723\u20133730. https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.007","journal-title":"Vaccine"},{"issue":"Pt 2","key":"13561_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1099\/vir.0.057521-0","volume":"95","author":"AB Ludi","year":"2014","unstructured":"Ludi AB, Horton DL, Li Y, Mahapatra M, King DP, Knowles NJ, Russell CA, Paton DJ, Wood JLN, Smith DJ, Hammond JM (2014) Antigenic variation of foot-and-mouth disease virus serotype A. J Gen Virol 95(Pt 2):384\u2013392. https:\/\/doi.org\/10.1099\/vir.0.057521-0","journal-title":"J Gen Virol"},{"issue":"7","key":"13561_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/14760584.2018.1492378","volume":"17","author":"M Mahapatra","year":"2018","unstructured":"Mahapatra M, Parida S (2018) Foot and mouth disease vaccine strain selection: current approaches and future perspectives. Expert Rev Vaccines 17(7):577\u2013591. https:\/\/doi.org\/10.1080\/14760584.2018.1492378","journal-title":"Expert Rev Vaccines"},{"issue":"27","key":"13561_CR32","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1016\/j.vaccine.2016.02.057","volume":"34","author":"M Mahapatra","year":"2016","unstructured":"Mahapatra M, Statham B, Li Y, Hammond J, Paton D, Parida S (2016) Emergence of antigenic variants within serotype A FMDV in the Middle East with antigenically critical amino acid substitutions. Vaccine 34(27):3199\u20133206. https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.057","journal-title":"Vaccine"},{"issue":"Pt 3","key":"13561_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1099\/0022-1317-71-3-629","volume":"71","author":"MG Mateu","year":"1990","unstructured":"Mateu MG, Mart\u00ednez MA, Capucci L, Andreu D, Giralt E, Sobrino F, Brocchi E, Domingo E (1990) A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol 71(Pt 3):629\u2013637. https:\/\/doi.org\/10.1099\/0022-1317-71-3-629","journal-title":"J Gen Virol"},{"issue":"1","key":"13561_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/s0042-6822(95)80045-x","volume":"206","author":"MG Mateu","year":"1995","unstructured":"Mateu MG, Camarero JA, Giralt E, Andreu D, Domingo E (1995) Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206(1):298\u2013306. https:\/\/doi.org\/10.1016\/s0042-6822(95)80045-x","journal-title":"Virology"},{"issue":"31\u201332","key":"13561_CR35","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1016\/j.vaccine.2004.06.040","volume":"22","author":"N Mattion","year":"2004","unstructured":"Mattion N, K\u00f6nig G, Seki C, Smitsaart E, Maradei E, Robiolo B, Duffy S, Le\u00f3n E, Piccone M, Sadir A, Bottini R, Cosentino B, Falczuk A, Maresca R, Periolo O, Bellinzoni R, Espinoza A, Torre JL, Palma EL (2004) Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease. Vaccine 22(31\u201332):4149\u20134162. https:\/\/doi.org\/10.1016\/j.vaccine.2004.06.040","journal-title":"Vaccine"},{"issue":"4","key":"13561_CR36","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1128\/jvi.66.4.1835-1840.1992","volume":"66","author":"KC McCullough","year":"1992","unstructured":"McCullough KC, De Simone F, Brocchi E, Capucci L, Crowther JR, Kihm U (1992) Protective immune response against foot-and-mouth disease. J Virol 66(4):1835\u20131840. https:\/\/doi.org\/10.1128\/jvi.66.4.1835-1840.1992","journal-title":"J Virol"},{"issue":"3","key":"13561_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1586\/14760584.8.3.347","volume":"8","author":"S Parida","year":"2009","unstructured":"Parida S (2009) Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Expert Rev Vaccines 8(3):347\u2013365. https:\/\/doi.org\/10.1586\/14760584.8.3.347","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"13561_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.20506\/rst.24.3.1632","volume":"24","author":"DJ Paton","year":"2005","unstructured":"Paton DJ, Valarcher JF, Bergmann I, Matlho OG, Zakharov VM, Palma EL, Thomson GR (2005) Selection of foot and mouth disease vaccine strains\u2013a review. Rev Sci Tech 24(3):981\u2013993","journal-title":"Rev Sci Tech"},{"issue":"11","key":"13561_CR39","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1128\/jvi.68.11.7092-7098.1994","volume":"68","author":"E Rieder","year":"1994","unstructured":"Rieder E, Baxt B, Lubroth J, Mason PW (1994) Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J Virol 68(11):7092\u20137098. https:\/\/doi.org\/10.1128\/jvi.68.11.7092-7098.1994","journal-title":"J Virol"},{"issue":"20","key":"13561_CR40","doi-asserted-by":"publisher","first-page":"12989","DOI":"10.1128\/jvi.79.20.12989-12998.2005","volume":"79","author":"E Rieder","year":"2005","unstructured":"Rieder E, Henry T, Duque H, Baxt B (2005) Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J Virol 79(20):12989\u201312998. https:\/\/doi.org\/10.1128\/jvi.79.20.12989-12998.2005","journal-title":"J Virol"},{"issue":"25\u201326","key":"13561_CR41","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1016\/s0264-410x(03)00364-5","volume":"21","author":"LL Rodriguez","year":"2003","unstructured":"Rodriguez LL, Barrera J, Kramer E, Lubroth J, Brown F, Golde WT (2003) A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21(25\u201326):3751\u20133756. https:\/\/doi.org\/10.1016\/s0264-410x(03)00364-5","journal-title":"Vaccine"},{"issue":"1","key":"13561_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1865-1682.2007.01013.x","volume":"55","author":"M Rweyemamu","year":"2008","unstructured":"Rweyemamu M, Roeder P, Mackay D, Sumption K, Brownlie J, Leforban Y, Valarcher JF, Knowles NJ, Saraiva V (2008) Epidemiological patterns of foot-and-mouth disease worldwide. Transbound Emerg Dis 55(1):57\u201372. https:\/\/doi.org\/10.1111\/j.1865-1682.2007.01013.x","journal-title":"Transbound Emerg Dis"},{"issue":"7","key":"13561_CR43","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1128\/jvi.71.7.5115-5123.1997","volume":"71","author":"D Sa-Carvalho","year":"1997","unstructured":"Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW (1997) Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 71(7):5115\u20135123. https:\/\/doi.org\/10.1128\/jvi.71.7.5115-5123.1997","journal-title":"J Virol"},{"key":"13561_CR44","doi-asserted-by":"publisher","unstructured":"Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. MolBiol Evol 30(12):2725\u20132729. https:\/\/doi.org\/10.1093\/molbev\/mst197","DOI":"10.1093\/molbev\/mst197"},{"issue":"21","key":"13561_CR45","doi-asserted-by":"publisher","first-page":"11675","DOI":"10.1128\/jvi.01254-12","volume":"86","author":"S Uddowla","year":"2012","unstructured":"Uddowla S, Hollister J, Pacheco JM, Rodriguez LL, Rieder E (2012) A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. J Virol 86(21):11675\u201311685. https:\/\/doi.org\/10.1128\/jvi.01254-12","journal-title":"J Virol"},{"issue":"2","key":"13561_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/lam.12354","volume":"60","author":"H Ullah","year":"2015","unstructured":"Ullah H, Siddique MA, Al Amin M, Das BC, Sultana M, Hossain MA (2015) Re-emergence of circulatory foot-and-mouth disease virus serotypes Asia1 in Bangladesh and VP1 protein heterogeneity with vaccine strain IND 63\/72. Lett Appl Microbiol 60(2):168\u2013173. https:\/\/doi.org\/10.1111\/lam.12354","journal-title":"Lett Appl Microbiol"},{"issue":"9","key":"13561_CR47","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/v13091886","volume":"13","author":"S Upadhyaya","year":"2021","unstructured":"Upadhyaya S, Mahapatra M, Mioulet V, Parida S (2021) Molecular basis of antigenic drift in serotype o foot-and-mouth disease viruses (2013\u20132018) from Southeast Asia. Viruses 13(9):1886. https:\/\/doi.org\/10.3390\/v13091886","journal-title":"Viruses"},{"issue":"Pt 1","key":"13561_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1099\/vir.0.19509-0","volume":"85","author":"HG van Rensburg","year":"2004","unstructured":"van Rensburg HG, Henry TM, Mason PW (2004) Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. J Gen Virol 85(Pt 1):61\u201368. https:\/\/doi.org\/10.1099\/vir.0.19509-0","journal-title":"J Gen Virol"},{"issue":"5","key":"13561_CR49","doi-asserted-by":"publisher","first-page":"e01315","DOI":"10.1128\/mra.01315-19","volume":"9","author":"D Vierra","year":"2020","unstructured":"Vierra D, Bertram MR, Palinski RM, Pauszek SJ, Hartwig EJ, Smoliga GR, Vu LT, Hoang BH, Phuong NT, Hung VV, Vu PP, Dung NK, Tien NN, Dong PV, Dung DH, Arzt J (2020) Foot-and-mouth disease virus serotype O\/CATHAY genome sequences from five outbreaks in vietnam, 2017 to 2019. Microbiol Resour Announc 9(5):e01315-e1319. https:\/\/doi.org\/10.1128\/mra.01315-19","journal-title":"Microbiol Resour Announc"},{"key":"13561_CR50","doi-asserted-by":"publisher","first-page":"113786","DOI":"10.1016\/j.jviromet.2019.113786","volume":"276","author":"T Willems","year":"2020","unstructured":"Willems T, De Vleeschauwer A, Perez-Filgueira M, Li Y, Ludi A, Lefebvre D, Wilsden G, Statham B, Haas B, Mattion N, Robiolo B, Beascoechea Perez C, Maradei E, Smitsaart E, La Torre J, De Clercq K (2020) FMD vaccine matching: inter laboratory study for improved understanding of r(1) values. J Virol Methods 276:113786. https:\/\/doi.org\/10.1016\/j.jviromet.2019.113786","journal-title":"J Virol Methods"},{"issue":"6","key":"13561_CR51","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1111\/tbed.12895","volume":"65","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Yang F, He J, Li J, Cao W, Li J, Xia Y, Guo J, Jin Y, Zhang K, Zheng H, Liu X (2018) First detection of foot-and-mouth disease virus O\/ME-SA\/Ind2001 in China. Transbound Emerg Dis 65(6):2027\u20132031. https:\/\/doi.org\/10.1111\/tbed.12895","journal-title":"Transbound Emerg Dis"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-025-13561-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-025-13561-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-025-13561-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:33:49Z","timestamp":1770294829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-025-13561-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13561"],"URL":"https:\/\/doi.org\/10.1007\/s00253-025-13561-8","relation":{},"ISSN":["1432-0614"],"issn-type":[{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved and performed according to the guidelines of the Gansu Ethical Review Committee (licence SYXK-GAN-2014\u2013003).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}